Physician

Sarah Parker Read

According to 2025 Medicare claims, Sarah Read (NPI: 1124381652) practices ophthalmology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HAWAII INC (NPI: 1124089446; TIN: 990300258) and primary practice location at 96701-4723.

Read's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 745 traditional Medicare patients, billed 13,898 HCPCS/CPT codes, and received $955,145 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 382 prescription claims across 156 beneficiaries totaling $27,791 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 20 records totaling $51,916. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $5,783 to $955,145. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $12,072 and ending at $27,791. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$504K$1.0M2016 Medicare payment: $5,783 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $39,028 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $92,613 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $705,567 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $893,213 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $709,280 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $936,839 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,008,829 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $955,145 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016113124$5,783
2017208325$39,028
2018220565$92,613
20196174,143$705,567
20206735,448$893,213
20215953,950$709,280
20227046,481$936,839
202375212,286$1,008,829
202474513,898$955,145

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$80K$161K2015 Drug cost: $12,072 (USD; Tot_Drug_Cst)2016 Drug cost: $23,639 (USD; Tot_Drug_Cst)2017 Drug cost: $10,416 (USD; Tot_Drug_Cst)2018 Drug cost: $42,122 (USD; Tot_Drug_Cst)2019 Drug cost: $73,269 (USD; Tot_Drug_Cst)2020 Drug cost: $160,611 (USD; Tot_Drug_Cst)2021 Drug cost: $146,216 (USD; Tot_Drug_Cst)2022 Drug cost: $64,466 (USD; Tot_Drug_Cst)2023 Drug cost: $45,670 (USD; Tot_Drug_Cst)2024 Drug cost: $27,791 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201554274$12,072
201682283$23,639
201790189$10,416
2018181663$42,122
2019166440$73,269
2020167434$160,611
2021145373$146,216
2022152395$64,466
2023124383$45,670
2024156382$27,791

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system537682$97
67028Injection of drug into eye211660$95
92012Established patient problem focused exam of visual system274578$73
92134Imaging of retina6871,360$33
92250Photography of the retina179204$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium502,207$9,010
ProlensaBromfenac Sodium191,003$6,866
Prednisolone AcetatePrednisolone Acetate503,417$3,035
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha1092,262$1,311
Brimonidine TartrateBrimonidine Tartrate13951$942

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$370Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.14$51,546Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sarah Parker Read?

Tedicare shows public-source Medicare data for Sarah Parker Read (NPI 1124381652), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Parker Read have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sarah Parker Read?

Sarah Parker Read is linked to RETINA CONSULTANTS OF HAWAII INC (billing NPI 1124089446) in the available physician profile data.

Does Sarah Parker Read have Open Payments data?

Sarah Parker Read has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.